Key result
Prostaglandin E1 in lipid microspheres is linked to improved peripheral vascular disease treatment.
Why the study?
Does Prostaglandin E1 incorporated in lipid microspheres improve treatment effectiveness in patients with peripheral vascular disease?
Does Prostaglandin E1 incorporated in lipid microspheres improve treatment effectiveness in patients with peripheral vascular disease?
Prostaglandin E1 incorporated in lipid microspheres appears to be a more effective formulation for treating peripheral vascular disease.
May support lipid microsphere PGE1 for peripheral vascular disease; hypothesis-generating, requiring randomized confirmation before practice change.
Y Mizushima, A Yanagawa, K Hoshi; Prostaglandin E1 is more effective, when incorporated in lipid microspheres, for treatment of peripheral vascular disease
No takes yet. Share an insight, caveat, or question.
Mizushima et al. (1983) studied this question. Prostaglandin E1 incorporated in lipid microspheres is more effective for the treatment of peripheral vascular diseases in humans.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: